Alaunos Therapeutics | ZIOP - Ebitda


Alaunos Therapeutics reported $-21.02M in EBITDA for its fiscal quarter ending in March of 2021.





Ebitda Change Date
Alaunos Therapeutics USD -21.02M 1.33M Mar/2021
Amgen USD 3.86B 1.28B Mar/2026
AstraZeneca USD 5.16B 510M Jun/2026
Baxter International USD 309M 756M Mar/2026
Biogen USD 649.7M 76.5M Mar/2026
Bioline Rx USD -2.25M 1.7M Mar/2026
Bristol-Myers Squibb USD 4.24B 1.37B Mar/2026
Celltrion KRW 19.64B 1.85B Mar/2026
Corcept Therapeutics USD -49M 53.2M Mar/2026
Cspc Pharmaceutical CNY 2.19B 21.88M Dec/2024
Curis USD -12.3M 231K Sep/2023
Deva Holding AS TRY 882.9M 201.7M Sep/2023
Dianthus Therapeutics USD -46.46M 6.27M Mar/2026
Divis Laboratories Ltd INR 12.62B 3.28B Jun/2026
Gilead Sciences USD 3.51B 489M Mar/2026
GlaxoSmithKline GBP 3.51B 734M Jun/2026
Incyte USD 778.57M 410.6M Jun/2026
Intrexon USD -24.7M 2.92M Jun/2024
Ionis Pharmaceuticals USD -64.53M 135.49M Mar/2026
J&J USD 8.27B 1.08B Mar/2026
Kangmei Pharma CNY -12.72M 30.02M Mar/2026
Karyopharm Therapeutics USD -26.2M 1.83M Sep/2024
Knight Therapeutics CAD 24.45M 3.46M Dec/2025
Laboratorios Farma EUR 34.94M 102.95M Jun/2025
Malin Corporation EUR -1.1M 200K Dec/2024
Medical Developments International AUD 1.78M 3.78M Dec/2024
Merck USD -1.54B 7.84B Mar/2026
Neuren Pharmaceuticals AUD 11.14M 165.56M Dec/2025
Novartis USD 6.48B 1.19B Jun/2026
Organigram Holdings CAD -4.76M 10.02M Mar/2026
Pfizer USD 6.01B 18M Jun/2026
Pharma Mar EUR 700K 2.01M Jun/2026
PTC Therapeutics USD 61.98M 132.97M Mar/2026
Qiagen NV USD 148.09M 101.6M Mar/2026
Regeneron Pharmaceuticals USD 1.66B 695.2M Jun/2026
Roche Holding CHF 13.43B 744M Jun/2026
Sartorius EUR 280.5M 13.2M Jun/2026
Sino Biopharmaceutical CNY 2.59B 1.57B Dec/2024
TG Therapeutics USD 28.11M 23.58M Mar/2026
Tilray USD 8.36M 1.82M Sep/2025
Zealand Pharma A/S -379M 348.47M Mar/2026
Zhangzhou Pientzehuang Pharmaceutical CNY 882.7M 351.1M Mar/2026